[1]
Hassaneen, H.M.; Shetta, A.; Shawali, A.S. Hydrazidoyl halides in synthesis of Δ2-1,3,4-Selenadiazolin-5-ones. J. Heterocycl. Chem., 1980, 17(6), 1185-1187.
[2]
Shawali, A.S.; Hassaneen, H.M.; Shetta, A.F.; Osman, A.; Abdel-Galil, F. regioselectivity of reactions of 2-Furoyl-N-Aryl nitrile imine with some dipolarophiles. Heterocycles, 1982, 19, 57-66.
[3]
Awad, E.M.; Elwan, N.M.; Hassaneen, H.M.; Linden, A.; Heimgartner, H. New routes to fused isoquinolines. Helv. Chim. Acta, 2002, 85(1), 320-332.
[4]
Elwan, N.M.; Awad, E.M.; Hassaneen, H.M.; Linden, A.; Heimgartner, H. Synthesis of 1,2,4-Triazolo[4,3-a]Pyrimidine derivatives by cyclocondensation of a 2-Thioxopyrimidin-4(3H)-One with hydrazonoyl halides. Helv. Chim. Acta, 2003, 86(3), 739-749.
[5]
Hassaneen, H.M.; Hassaneen, H.M.E.; Mohammed, Y.S.; Pagni, R.M. Synthesis, reactions and antibacterial activity of 3-Acetyl[1,2,4]Triazolo[3,4-a]Isoquinoline derivatives using chitosan as heterogeneous catalyst under microwave irradiation. Zeitschrift für. Naturforsch. B, 2011, 66(3), 299-310.
[6]
Hassaneen, H.M.; Saleh, F.M.; Mohammed, Y.S.; Awad, E.M. A convenient regioselective synthesis of novel 1,4-phenylene-methylene-6,6′-bis-([1,2,4-triazolo]-[4,3-b][1,2,4]-triazin-7(1H)-ones). J. Heterocycl. Chem., 2017, 54(6), 3015-3022.
[7]
Hassaneen, H.M.; Wardakhan, W.W.; Mohammed, Y.S. Synthesis and reactions of pyrido[2,1-a]Isoquinolin-4-yl formimidate derivatives and antimicrobial activities of isolated products. J. Heterocycl. Chem., 2017, 54(5), 2850-2858.
[8]
Hassaneen, H.M.; Shawali, A.S.; Saleh, F.M. A Convenient synthesis of novel 1,3-phenylene bridged bis-heterocyclic compounds. J. Sulfur Chem., 2016, 37(3), 241-250.
[9]
Abdelhamid, A.O.; Hassaneen, H.M.; Shawali, A.S.; Párkányi, C. Reactions of α-Ketohydrazidoyl halides with some heterocyclic amines. Facile synthesis of arylazo derivatives of fused heterocycles with a bridgehead nitrogen atom. J. Heterocycl. Chem., 1983, 20(3), 639-643.
[10]
Abdelhamid, A.O.; Hassaneen, H.M.; Shawali, A.S. Synthesis of Pyrazolo[3,2-c]-1,2,4-Triazines from N-(5-Pyrazolyl)-α-Ketohydrazidoyl halides. J. Heterocycl. Chem., 1985, 22(2), 453-455.
[11]
Hassaneen, H.M.; Mousa, H.A.H.; Shawali, A.S. Chemistry of C-heteroarylnitrilimines. Synthesis and cycloaddition reactions of N-Phenyl-C-(2-Thienyl)Nitrilimine. J. Heterocycl. Chem., 1987, 24(6), 1665-1668.
[12]
Hassaneen, H.M.; Ead, H.A.; Elwan, N.M.; Shawali, A.S. A one step synthesis of 4-Cyanopyrazoles. Heterocycles, 1988, 27(12), 2857-2862.
[13]
Hassaneen, H.M.; Mousa, H.A.H.; Shawali, A.S. Selsctivity in cycloadditions of N-Aryl-C-(2-Thienyl) Nitrilimines to α, β- Disubstituted acrylonitriles. Sulfur Lett., 1988, 8, 217-227.
[14]
Hassaneen, H.M.; Shawali, A.S.; Elwan, N.M. Synthesis and cycloaddition reaction of N-Phenyl-C-Styrylmethanohydrazonyl bromide. Heterocycles, 1990, 31(2), 247-253.
[15]
Elwan, N.M.; Abdelhadi, H.A.; Abdallah, T.A.; Hassaneen, H.M. Synthesis of [1,2,4]Triazolo[3,4-a]Isoquinolines and Pyrrolo[2,1-a]Isoquinolines using α-Keto hydrazonoyl halides. Tetrahedron, 1996, 52(10), 3451-3456.
[16]
Hassaneen, H.M.; Abdelhadi, H.A.; Abdallah, T.A. Novel synthesis of 1,2,4-triazolo[4,3- a]pyrimidin-5-one derivatives. Tetrahedron, 2001, 57(51), 10133-10138.
[17]
Shawali, A.S.; Párkanyi, C. Hydrazidoyl halides in the synthesis of heterocycles. J. Heterocycl. Chem., 1980, 17(5), 833-854.
[18]
Shawali, A.S. Reactions of hydrazidoyl halides with sulfer compounds. Heterocycles, 1983, 20(11), 2239-2285.
[19]
Ghozlan, S.A.S.; Abdelhamid, I.A.; Elnagdi, M.H.; Gaber, H.M. Studies on enaminonitriles: A new synthesis of 1,3-Substituted Pyrazole-4-Carbonitrile. J. Heterocycl. Chem., 2005, 42(6), 1185-1189.
[20]
Wolkoff, P. A new method of preparing hydrazonyl halides. Can. J. Chem., 1975, 53(9), 1333-1335.
[21]
Abdelhamid, A.O.; Rateb, N.M.; Dawood, K.M. Reactions with hydrazonoyl halides XXX: Synthesis of some 2,3-Dihydro-1,3,4-Thiadiazoles and unsymmetrical azines containing benzothiazole moiety. Phosphorus Sulfur Silicon Relat. Elem., 2000, 167(1), 251-258.
[22]
Abdelhamid, A.O.; Abdelall, E.K.A.; Zaki, Y.H. Reactions with hydrazonoyl halides 62: Synthesis and antimicrobial evaluation of some new Imidazo[1,2‐a]Pyrimidine, Imidazo [1,2‐a]Pyridine, Imdazo[1,2‐b]Pyrazole, and quinoxaline derivatives. J. Heterocycl. Chem., 2010, 47(2), 477-482.
[23]
Shawali, A.S. Reactions of heterocyclic compounds with nitrilimines and their precursors. Chem. Rev., 1993, 93(8), 2731-2777.
[24]
Shawali, A.S.; Abdallah, M.A. The chemistry of heterocyclic hydrazonoyl halides. Adv. Heterocycl. Chem., 1995, 63, 277-338.
[25]
Shawali, A.S.; Mosselhi, M.A.N. Hydrazonoyl halides: Useful Building blocks for the synthesis of arylazoheterocycles. J. Heterocycl. Chem., 2003, 40(4), 725-746.
[26]
Shawali, A.S.; Edrees, M.M. Reactions of Nitrilimines with heterocyclic amines and enamines. Convenient methodology for synthesis and annulation of heterocycles. Gen. Pap. Ark., 2006, ix, 292-365.
[27]
Shawali, A.S.; Samy, N.A. Hydrazonoyl halides: Their versatile biological activities. Open Bioactive Compd. J., 2009, 2(1), 8-16.
[28]
Huisgen, R. 1,3-Dipolar cycloadditions. Past and future. Angew. Chem. Int. Ed. Engl., 1963, 2(10), 565-598.
[29]
Heusgen, R. Mechanism of 1,3-Dipolar cycloadditions. Reply. J. Org. Chem., 1968, 33(6), 2291-2297.
[30]
Huisgen, R. Kinetics and mechanism of 1,3-Dipolr cycloadditions. Angew. Chem. Int. Ed. Engl., 1963, 2(11), 633-645.
[31]
Hegarty, A.F.; Cashman, M.P.; Scott, F.L. Synthesis of aliphatic hydrazonyl bromides and kinetics of their conversion into hydrazides. J. Chem. Soc., Perkin Trans. 2, 1972, 10, 1381-1385.
[32]
Shawali, A.S.; Hassaneen, H.M. Chemistry of aliphatic hydrazonyl bromides. Part II– Reactions with carbanions of active methylene compounds. Indian J. Chem., 1976, 14b, 549-550.
[33]
Yamini, L.; Vijjulatha, M. Inhibitors of human dihydrofolate reductase: A computational design and docking studies using glide. E-J. Chem., 2008, 5(2), 263-270.
[34]
Banjanac, M.; Tatic, I.; Ivezic, Z.; Tomic, S.; Dumic, J. Pyrimido- pyrimidines : A novel class of dihydrofolate reductase inhibitors. Food Technol. Biotechnol., 2009, 47, 236-245.
[35]
Ghozlan, S.A.S.; Mohamed, M.F.; Ahmed, A.G.; Shouman, S.A.; Attia, Y.M.; Abdelhamid, I.A. Cytotoxic and antimicrobial evaluations of novel apoptotic and anti-angiogenic spiro cyclic 2-Oxindole derivatives of 2-Amino-Tetrahydroquinolin-5-One. Arch. Pharm. (Weinheim), 2015, 348(2), 113-124.
[36]
Mohamed, M.F.; Darweesh, A.F.; Elwahy, A.H.M.; Abdelhamid, I.A. Synthesis, characterization and antitumor activity of novel tetrapodal 1,4-dihydropyridines: P53 Induction, Cell Cycle arrest and low damage effect on normal cells induced by genotoxic factor H2O2. RSC Advances, 2016, 6(47), 40900-40910.
[37]
Mohamed, M.F.; Mohamed, M.S.; Fathi, M.M.; Shouman, S.A.; Abdelhamid, I.A. Chalcones incorporated pyrazole ring inhibit proliferation, Cell cycle progression, angiogenesis and induce apoptosis of MCF7 cell line. Anticancer. Agents Med. Chem., 2014, 14(9), 1282-1292.
[38]
Mohamed, M.F.; Attia, Y.M.; Shouman, S.A.; Abdelhamid, I.A. Anticancer activities of new N-Hetaryl-2-Cyanoacetamide derivatives incorporating 4,5,6,7-Tetrahydrobenzo[b]Thiophene moiety. Anticancer. Agents Med. Chem., 2017, 17(8), 1084-1092.
[39]
Mohamed, M.F.; Hassaneen, H.M.; Abdelhamid, I.A. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel Tetrahydro-[1,2,4]Triazolo[3,4-a]Isoquinoline Chalcones. Eur. J. Med. Chem., 2018, 143(1), 532-541.
[40]
Salama, S.K.; Mohamed, M.F.; Darweesh, A.F.; Elwahy, A.H.M.; Abdelhamid, I.A. Molecular docking simulation and anticancer assessment on human breast carcinoma cell line using novel Bis(1,4-Dihydropyrano[2,3-c]Pyrazole-5-Carbonitrile) and Bis(1,4-Dihydropyrazolo[4′,3′:5,6]Pyrano[2,3-b]Pyridine-6-Carbonitrile) derivatives. Bioorg. Chem., 2017, 71, 19-29.
[41]
Ibrahim, N.S.; Mohamed, M.F.; Elwahy, A.H.M.; Abdelhamid, I.A. Biological activities and docking studies on novel bis 1,4-dhps linked to arene core via ether or ester linkage. Lett. Drug Des. Discov., 2018, 15, 1036-1045.
[42]
Mohamed, M.F.; Samir, N.; Ali, A.; Ahmed, N.; Ali, Y.; Aref, S.; Hossam, O.; Mohamed, M.S.; Abdelmoniem, A.M.; Abdelhamid, I.A. Apoptotic induction mediated P53 mechanism and Caspase-3 activity by novel promising cyanoacrylamide derivatives in breast carcinoma. Bioorg. Chem., 2017, 73, 43-52.
[43]
Mohamed, M.F.; Abdelmoniem, A.M.; Elwahy, A.H.M.; Abdelhamid, I.A. DNA Fragmentation, Cell cycle arrest, and docking study of novel bis Spiro-Cyclic 2-oxindole of Pyrimido[4,5-b]Quinoline-4,6-Dione derivatives against breast carcinoma. Curr. Cancer Drug Targets, 2018, 18(4), 372-381.
[44]
Abdella, A.M.; Mohamed, M.F.; Mohamed, A.F.; Elwahy, A.H.M.; Abdelhamid, I.A. Novel Bis(Dihydropyrano[3,2-c]Chromenes): Synthesis, antiproliferative effect and molecular docking simulation. J. Heterocycl. Chem., 2018, 55(2), 498-507.
[45]
Bauer, A.W.; Kirby, W.M.; Sherris, J.C.; Turck, M. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol., 1966, 45(4), 493-496.
[46]
Pfaller, M.A.; Burmeister, L.; Bartlett, M.S.; Rinaldi, M.G. Multicenter evaluation of four methods of yeast inoculum preparation. J. Clin. Microbiol., 1988, 26(8), 1437-1441.
[47]
Nccls. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard, 2nd ed; Serving the World’s Medical Science Community Through Voluntary Consensus, 2002, Vol. 22, .
[48]
Rex, J.H.; Johnson, E.M.; Ghannoum, M.A.; Knapp, C.C.; Alexander, B.D.; Motyl, M.R.; Andes, D.; Ostrosky-Zeichner, L.; Brown, S.D.; Pfaller, M.A. Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts: Approved Guideline M44-A; , 2009. Vol. 24.
[49]
Jordão, A.K.; Novais, J.; Leal, B.; Escobar, A.C.; dos Santos Júnior, H.M. Castro, H.C.; Ferreira, V.F. Synthesis using microwave irradiation and antibacterial evaluation of new N,O-Acetals and N,S-Acetals derived from 2-Amino-1,4-naphthoquinones. Eur. J. Med. Chem., 2013, 63, 196-201.
[50]
Geng, Z.Z.; Zhang, J.J.; Lin, J.; Huang, M.Y.; An, L.K.; Zhang, H.B.; Sun, P.H.; Ye, W.C.; Chen, W.M. Novel cajaninstilbene acid derivatives as antibacterial agents. Eur. J. Med. Chem., 2015, 100, 235-245.
[51]
Suresh, N.; Nagesh, H.N.; Renuka, J.; Rajput, V.; Sharma, R.; Khan, I.A.; Gowri, C.S.K.V. Synthesis and evaluation of 1-Cyclopropyl-6-Fluoro-1,4-Dihydro-4-Oxo-7-(4-(2-(4-Substitutedpiperazin-1-Yl) Acetyl)Piperazin-1-Yl)Quinoline-3-carboxylic acid derivatives as anti-tubercular and antibacterial agents. Eur. J. Med. Chem., 2014, 71, 324-332.
[52]
Ghose, A.K.; Viswanadhan, V.N.; Wendoloski, J.J. Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: An analysis of ALOGP and CLOGP methods. J. Phys. Chem. A, 1998, 102(21), 3762-3772.
[53]
Gibson, A.E.; Arris, C.E.; Bentley, J.; Boyle, F.T.; Curtin, N.J.; Davies, T.G.; Endicott, J.A.; Golding, B.T.; Grant, S.; Griffin, R.J. Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with o6-substituted guanine derivatives. J. Med. Chem., 2002, 45(16), 3381-3393.
[54]
Rashad, A.E.; Heikal, O.A.; El-Nezhawy, A.O.H.; Abdel-Megeid, F.M.E. Synthesis and isomerization of thienotriazolopyrimidine and thienotetrazolopyrimidine derivatives with potential Anti-Inflammatory activity. Heteroatom Chem., 2005, 16(3), 226-234.
[55]
Hosmane, R.S.; Lim, B.B.; Burnett, F.N. Rearrangements in heterocyclic synthesis: A novel translocation of an (N-Amino-N-Methylamino)Methylene group from a heterocyclic N-Amino-N-Methylformamidine side chain to the vinylogous nitrile function. J. Org. Chem., 1988, 53(3), 382-386.
[56]
Rashad, A.E.; Heikal, O.A.; El-Nezhawy, A.O.H.; Abdel-Megeid, F.M.E. Synthesis and isomerization of thienotriazolopyrimidine and thienotetrazolopyrimidine derivatives with potential anti-inflammatory activity. Heteroatom Chem., 2005, 16(3), 226-234.
[57]
Edition, I.; Chemistry, O. Studies on mechanisms of the rearrangement of thieno [3,2e][1,2, 4] Triazolo [4, 3c] Pyrimidines into Thieno [3,2e][1,2,4] Triazolo [1,5c] Pyrimidines. Russ. Chem. Bull., 2006, 55(12), 2247-2255.
[58]
Abdel-Fattah, B.; Kandeel, M.M.; Abdel-Hakeem, M.; Fahmy, Z.M. Synthesis of certain fused thienopyrimidines of biological interest. J. Chin. Chem. Soc., 2006, 53(2), 403-412.
[59]
Chopra, I.; Roberts, M. Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev., 2001, 65(2), 232-260.
[60]
Hopkins, A.L.; Groom, C.R. The druggable genome. Nat. Rev. Drug Discov., 2002, 1(9), 727-730.
[61]
Kubinyi, H. Opinion: Drug research: Myths, Hype and Reality. Nat. Rev. Drug Discov., 2003, 2(8), 665-668.
[62]
Shier, W. Mammalian cell culture on $5 a Day: A laboratory manual
of low cost methods. Los Banos, Univ. Philipp, 1991. 64.
36
4
